product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [PE/Cy7] - Chimeric
catalog :
NBP2-52687PECY7
quantity :
0.1 ml
price :
599 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
PE/Cy7
clone name :
R4930 (Oxelumab)
reactivity :
human
application :
flow cytometry
more info or order :
product information
brand :
Novus
master code :
NBP2-52687PECY7
SKU :
NBP2-52687PECY7
product name :
OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [PE/Cy7] - Chimeric
sizes available :
0.1 ml
description :
The OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) [PE/Cy7] - Chimeric from NBP2-52687PECY7 is a 6.3e-05 antibody to . This antibody reacts with human.
target :
OX40 Ligand/TNFSF4
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
R4930 (Oxelumab)
conjugate :
PE/Cy7
all_available conjugate :
PE/Cy7
dilution :
Flow Cytometry
host :
Rabbit
immunogen :
Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
isotype :
IgG Kappa
purity :
Protein A purified
species :
Human
specificity :
Binds to human OX40L.
gene symbol :
TNFSF4
applications :
Flow Cytometry
extended description :
Recombinant Monoclonal Antibody
USD :
599 USD
product details :
Recombinant Monoclonal Antibody
alt names :
CD134 ligand, CD134L, CD252, CD252 antigen, Glycoprotein Gp34, gp34, OX40 antigen ligand, OX40 ligand, OX40L, OX-40L, OX4OL, TAX transcriptionally-activated glycoprotein 1, tax-transcriptionally activated glycoprotein 1 (34kD), tax-transcriptionally activated glycoprotein 1, 34kD, tumor necrosis factor (ligand) superfamily, member 4, tumor necrosis factor ligand superfamily member 4, TXGP1
storage :
Store at 4C in the dark. Do not freeze.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.